Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Jonnyboy85on Nov 26, 2020 11:07am
149 Views
Post# 31978575

RE:RE:Would be great if we break that psychological wall at 0.70$

RE:RE:Would be great if we break that psychological wall at 0.70$ Just an ammendment to your post, the 0.73 applies as an appropriate valuation because the shares in the offering are obviously the same as the shares on the open market, but the warrants don't because they have different terms than the warrants that are available on the market now.
Bully88 wrote: I believe we have established thanks to Jonnyboy, 

Appropriate vaule at this time is .73c and warrant at .05c making a total of .78c

Hopefully this ammendment on their financial status will bring us around that range.

We all know this company is extremely undervalued at this moment, and it is only a matter of time before it corrects to a more apporpriate price.

anywhere in the .70s before the closing is appropriate IMO

After closing. Anything Under 2.00 is undervalued until more Aristotle news and/or More Covid related revenue streams/major partnerships IMO

After Aristotle news, anything under 4.00 is highly undervalued IMO


<< Previous
Bullboard Posts
Next >>